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In vivo positron emission tomography of neuroinflammation has mainly focused on the
evaluation of glial cell activation using radiolabeled ligands. However, the non-invasive
imaging of neuroinflammatory cell proliferation has been scarcely evaluated so far. In vivo
and ex vivo assessment of gliogenesis after transient middle cerebral artery occlusion
(MCAO) in rats was carried out using PET imaging with the marker of cell proliferation
3′-Deoxy-3′-[18F] fluorothymidine ([18F]FLT), magnetic resonance imaging (MRI) and
fluorescence immunohistochemistry. MRI-T2W studies showed the presence of the
brain infarction at 24 h after MCAO affecting cerebral cortex and striatum. In vivo PET
imaging showed a significant increase in [18F]FLT uptake in the ischemic territory at day 7
followed by a progressive decline from day 14 to day 28 after ischemia onset. In addition,
immunohistochemistry studies using Ki67, CD11b, and GFAP to evaluate proliferation
of microglia and astrocytes confirmed the PET findings showing the increase of glial
proliferation at day 7 after ischemia followed by decrease later on. Hence, these results
show that [18F]FLT provides accurate quantitative information on the time course of glial
proliferation in experimental stroke. Finally, this novel brain imaging method might guide
on the imaging evaluation of the role of gliogenesis after stroke.
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INTRODUCTION
Gliogenesis is the process by which glial progenitor cells differentiate into mature glia during
development, and in the adult brain to maintain and regulate brain function (Lee et al., 2000).
Following stroke, neurovascular disturbances lead to a massive neuroinflammatory reaction
through the activation of glial cells such as microglia and astrocytes that amplifies ischemic
damage and neuronal death (Moskowitz et al., 2010). In turn, proliferation of glial cells underlies
compensatory mechanisms that likely contributes to neuronal restoration after brain injury
(Rusznak et al., 2016).
In vivo positron emission tomography (PET) of neuroinflammation has been mainly focused
on the evaluation of microglia/macrophage and astrocytic activation using radiolabeled ligands
for the Translocator protein 18 kDa (TSPO) (Martin et al., 2010; Dupont et al., 2017; Pulagam
et al., 2017). TSPO, a mitochondrial protein expressed in reactive glial cells, is considered the
hallmark for neuroinflammation, as it is highly expressed after inflammatory reaction while low
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expression is shown in the healthy brain (Martin et al., 2010).
For this reason, this biomarker has been widely used to monitor
neuroinflammatory activation in major neurological diseases i.e.,
stroke, Alzheimer’s disease, Parkinson’s disease and multiple
sclerosis, among others (Dupont et al., 2017). Despite the
imaging of glial activation has been fully characterized with TSPO
radiotracers during the last decade, the investigation of glial
cell proliferation using PET imaging still remains unexplored.
PET imaging of cellular proliferation has been mainly limited
to the use of 3′-Deoxy-3′-[18F]fluorothymidine ([18F]FLT) in
both preclinical and clinical routine (McHugh et al., 2018;
Schelhaas et al., 2018; Bashir et al., 2020). [18F]FLT is an analog
of thymidine which is phosphorylated by thymidine kinase-1
(TK-1), an enzyme expressed during the DNA synthesis and up-
regulated during the S phase of the cell cycle (Shields et al.,
1998). Once phosphorylated, [18F]FLT cannot be incorporated
into the DNA and is metabolically trapped inside the cells.
For this reason, the uptake and accumulation of [18F]FLT
are used as surrogate of cellular proliferation (Cieslak et al.,
2016). [18F]FLT has been extensively used in the field of
oncology to characterize tumors and predict the response to
personalized therapeutic approaches (Schelhaas et al., 2017).
Therefore, the main application of this radiotracer in neurology
has been restricted to the diagnosis of glioblastoma (Nikaki
et al., 2017; Brahm et al., 2018). Nevertheless, few studies have
reported the visualization of endogenous neural stem cells in
living animals using [18F]FLT after focal cerebral ischemia,
that could be used to monitor the effect of drugs aimed at
expanding the neural stem cell niche (Rueger et al., 2010, 2012).
Moreover, previous studies from our group and others showed
that the lack of toll-like receptor 4 which is mainly expressed
in microglia and astrocytes after brain ischemia, was able to
increase neurogenesis using [18F]FLT-PET in the subventricular
area after focal ischemia in mice (Caso et al., 2007, 2008;
Moraga et al., 2016). Despite these findings, the use of [18F]FLT
to monitor proliferation of glial cells has not been explored
before. The purpose of the present study was to investigate non-
invasively gliogenesis in the rat brain after cerebral ischemia
using [18F]FLT-PET and immunohistochemistry. In particular,
we were interested in clarifying the relationship of the [18F]FLT
uptake and proliferative microglia/macrophages and astrocytes in
a preclinical model of ischemic stroke in rats. Hence, these results
provide valuable information about the use of a novel imaging
methodology to follow up proliferation of glial cells in vivo after
cerebral ischemia. This research might ultimately contribute to
a better design of novel diagnostic and therapeutic strategies for
neurologic diseases such as stroke.
MATERIALS AND METHODS
Cerebral Ischemia and Experimental
Set-Up
Eight-weeks old male Sprague-Dawley rats (n = 32; 307 ± 4.3 g
body weight; Janvier, France) were used for both non-
invasive imaging and immunohistochemical studies. Animal
experimental protocols and relevant details regarding welfare
were approved by the animal ethics committee of CIC
biomaGUNE and were conducted in accordance with the
ARRIVE guidelines and Directives of the European Union
on animal ethics and welfare. Rats were anaesthetized with
2.5% isoflurane in 100% O2 and transient focal ischemia was
produced by a 90 min intraluminal occlusion of the middle
cerebral artery (MCAO) followed by reperfusion as described
previously (Justicia et al., 2001). Ischemic rats were subjected
to T2-weighted (T2W) MRI scans at 24 h after reperfusion
to select rats presenting cortico-striatal infarction for inclusion
in the PET studies. 16 rats were used to carry out [18F]FLT-
PET imaging studies. Eight of them were only scanned before
ischemic insult. A different set of rats (n = 8) was scanned at
7 days after ischemia; of these, five animals were re-scanned
at days 14 and 28 after ischemia. Overall, five animals were
subjected to the three PET imaging sessions. Not all animals
were subjected to the complete PET imaging protocol due
to technical issues with the PET scanner at day 14 (n = 5)
after stroke. In addition, one animal died before last PET
session at day 28 (n = 7) after ischemia. In all cases, [18F]FLT
uptake in the brain was determined. In addition, additional
16 rats were used to perform immunohistochemical studies for
proliferation of glial cells before (control) and at days 7, 14, and
28 after ischemia.
Magnetic Resonance Imaging
T2W-MRI scans were used to include rats in the PET study and
to evaluate the infarction volume. Scans were performed in rats
anaesthetized with 4% isoflurane and maintained by 2–2.5% of
isoflurane in a 30/70% mixture of O2/N2. Animals were placed
into a rat holder compatible with the MRI acquisition system and
maintained normothermia using a water-based heating blanket
at 37◦C. To ensure animal welfare, temperature and respiration
rate were continuously monitored while they remain in the
MRI magnet, using a SAII M1030 system (SA Instruments, NY,
United States). MRI in vivo studies were performed on a 7T
horizontal bore Bruker Biospec USR 70/30 MRI system (Bruker
Biospin GmbH, Ettlingen, Germany), interfaced to an AVANCE
III console, and with a BGA12-S imaging gradient insert
(maximal gradient strength 400 mT/m, switchable within 80 µs).
These measurements were performed with a 72 mm volumetric
quadrature coil for excitation and a 20 mm rat brain surface coil
for reception. The imaging session started with the acquisition
of a scout scan, which was used to plan the whole study
focusing on the region of interest. T2-W images were acquired
with a Bruker’s RARE (Rapid Acquisition with Relaxation
Enhancement) sequence (Effective TE = 40 ms, TR = 4400 ms,
NA = 2; Matrix = 256× 256 points; FOV = 25.6 mm× 25.6 mm;
spatial resolution = 100 µm × 100 µm; 24 contiguous slices of
1 mm thickness covering the whole brain), which was used to
quantify the volume of the lesion. For the image analysis, regions
of interest (ROIs) were manually defined by the same researcher
a blind fashion using the open source software 3D Slicer image
analysis software (version 4.81) for each rat on the region of
increased signal in the ipsilateral hemisphere. The total lesion
1http://www.slicer.org
Frontiers in Neuroscience | www.frontiersin.org 2 July 2020 | Volume 14 | Article 793
fnins-14-00793 July 28, 2020 Time: 17:59 # 3
Ardaya et al. Imaging of Gliogenesis After Stroke
volume was calculated by summing the area of the infarcted
regions of all slices affected by the lesion.
Radiochemistry
The synthesis of 3′-Deoxy-3′-[18F]fluorothymidine ([18F]FLT)
was performed as described earlier (Machulla et al., 2000), using
a TRACERlab FXFN synthesis module (GE Healthcare). In
brief, [18F]Fluoride was produced via the 18O(p,n)18F nuclear
reaction in 2.9 ml of 98% 18O-enriched water. The [18F]F− was
trapped in a pre-conditioned QMA cartridge and transferred
to the reactor by sequential elution with a solution of K2CO3
(3.5 mg) in water (0.5 ml) and a solution of Kryptofix K2.2.2
(15 mg) in acetonitrile (1 ml). After azeotropic evaporation,
a solution containing the precursor (10 mg of 5′-O-Benzoyl-
2,3′-anhydrothymidine in 1 ml of dimethylsulfoxide) was added
and the fluorination reaction was allowed to occur at 100◦C
for 10 min. The reactor was then cooled at room temperature
and 0.35 ml of 1% NaOH aqueous solution were added for
the hydrolysis of protecting groups (5 min at 50◦C). Finally,
0.75 ml of 0.2 M NaH2PO4 aqueous solution and 1.75 ml of
mobile phase, consisting of 0.01 M NaH2PO4 solution (90%)
and ethanol (10%), were added and the mixture was purified by
HPLC, using a VP125/10 Nucleosil 100-7C18 semipreparative
column (Macherey-Nagel) as stationary phase. The collected
fraction (retention time = 13,14 min) was filtered through
a 0.22 µm sterile filter to yield the final [18F]FLT solution.
Average radiochemical yield was 7.5 ± 1.1% (EOS) in an overall
production time of ca. 60 min. Radiochemical purity was higher
than 95% in all cases.
Positron Emission Tomography Scans
and Data Acquisition
PET scans were performed using an eXplore Vista PET-CT
camera (GE Healthcare, Waukesha, WI, United States). Scans
were performed in rats anaesthetized with 4% isoflurane and
maintained by 2–2.5% of isoflurane in 100% O2. Animals were
placed into a rat holder compatible with the PET acquisition
system and maintained normothermia using a water-based
heating blanket at 37◦C. To ensure animal welfare, temperature
and respiration rate were continuously monitored while they
remain in the PET scanner, using a SAII M1030 system (SA
Instruments, NY, United States). The tail vein was catheterized
with a 24-gage catheter for intravenous administration of the
radiotracer. For longitudinal assessment of [18F]FLT uptake after
ischemia, control animals (n = 8) and ischemic animals at days 7
(n = 8), 14 (n = 5), and 28 (n = 7) after ischemia were scanned.
The radioactivity (±70 MBq) controlled for animal weight
was injected and dynamic brain images were acquired for 18
frames and 60 min in the 400–700 keV energetic window. After
each PET scan, CT acquisitions were also performed (140 mA
intensity, 40 kV voltage), to provide anatomical information of
each animal as well as the attenuation map for the later PET
image reconstruction. Dynamic acquisitions were reconstructed
(decay and CT-based attenuation corrected) with filtered back
projection (FBP) using a Ramp filter with a cutoff frequency
of 0.5 mm−1.
Positron Emission Tomography Image
Analysis
PET images were analyzed using PMOD image analysis software
(version 3.5, PMOD Technologies Ltd., Zurich, Switzerland). To
verify the anatomical location of the signal, PET images were co-
registered to the anatomical data of a MRI rat brain template.
Two type of Volumes of Interest (VOIs) were established as
follows: (1) A first set of VOIs was defined to study the whole
brain [18F]FLT PET signal. Whole brain VOIs were manually
drawn in both the entire ipsilateral and contralateral hemispheres
on slices of a MRI (T2W) rat brain template provided by
PMOD software. (2) A second set of VOIs was automatically
generated in the cerebral cortex and the striatum by using the
regions proposed by the PMOD rat brain template, to study the
evolution of [18F]FLT PET signal in these specific regions in
both the ipsilateral and contralateral cerebral hemispheres. The
last five frames (last 15 min of acquisition) were summed to
quantify radiotracer uptake. Average values in each ROI were




Immunohistochemistry staining was carried out at control
(n = 4), day 7 (n = 4), day 14 (n = 4), and day 28
(n = 4) after reperfusion and the “n” of each group was
randomly assigned. The brain was removed, frozen and cut
in 5-µm-thick sections in a cryostat. Sections were fixed in
4% paraformaldehyde during 15 min, washed with phosphate-
buffered saline (PBS) and incubated 5 min in NH4Cl, following
by two PBS rinse and methanol-acetone (1:1) permeabilization
during 5 min at −20◦C. After PBS washing, samples were
saturated with a solution of bovine serum albumin (BSA)
5%/Tween 0.5% in PBS during 15 min at room temperature,
and incubated during 2 h at room temperature with primary
antibodies BSA (5%)/Tween (0.5%) in PBS. Sections were
stained for Ki67 with rabbit anti-rat Ki67 (1:400, AbCam,
Cambridge, United Kingdom), for CD11b with mouse anti-rat
CD11b (1:300; Serotec, Raleigh, NC, United States) and for
the glial fibrillary acidic protein (GFAP) with chicken anti-rat
GFAP (1:500; AbCam, Cambridge, United Kingdom). Sections
were washed (3 × 10 min) in PBS and incubated for 1 h
at room temperature with secondary antibodies Alexa Fluor
594 goat anti-rabbit IgG, Alexa Fluor 488 goat anti-mouse
IgG and Alexa Fluor 647 goat anti-chicken IgG (Molecular
Probes, Life Technologies, Madrid, Spain, 1:1,000) in BSA
5%/Tween 0.5% in PBS, washed again (3 × 10 min) in PBS,
and mounted with a prolong antifade kit with DAPI in slices
(Molecular Probes Life Technologies, Madrid). Standardized
images acquisition was performed with the Panoramic MIDI
II automated digital slide scanner (3DHistech Ltd., Hungary)
and the Leica SP8 microscope (Hospitalet de Llobregat, Spain).
Cells were manually counted in ten representative and different
fields at Bregma: circa 0.50 mm and 40× magnification in a
blind-fashion to avoid bias by using Image J (Version 2.0.0-rc-
69/11.52p, NIH) software.
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Statistical Analyses
For PET, the percentage of injected dose per cubic centimeter
(%ID/cc) within each region and time point following
cerebral ischemia were averaged and compared with the
averaged baseline control values (day 0) using one-way
ANOVA followed by Dunnet’s multiple-comparison tests
for post hoc analysis. Likewise, cellular expression of
both Ki67+/CD11b+ and Ki67+/GFAP+ at control and
days 7, 14, and 28 after ischemia were compared using
the same statistical analysis than that for PET imaging.
The level of significance was regularly set at p < 0.05.
Statistical analyses were performed with GraphPad Prism
version 8 software.
RESULTS
The evaluation of in vivo gliogenesis was explored by PET
using the radiotracer [18F]FLT during the first month
after transient focal ischemia in rats. All the images were
quantified in standard units, i.e.,%ID/cc of [18F]FLT. The
images with normalized color scale illustrate the evolution
of the PET signals before (control) and at 7, 14, and 28 days
after ischemia onset (Figures 1A,C–E). Hyperintensity of
MRI-T2W images showed the edema formation as result
of the evolution of the brain infarction at day 1 after
reperfusion (Figure 1B). All animals subjected to PET
studies showed cortico-striatal MRI alterations (mean ± sd:
298± 71 mm3, n = 8).
Imaging Glial Proliferation Using [18F]FLT
PET After Cerebral Ischemia
In vivo imaging of glial proliferation was evaluated with the
uptake of [18F]FLT in the ipsilateral and contralateral whole
brain, cerebral cortex and striatum before (control) and at 7,
14, and 28 days after MCAO (Figure 2). All brain regions
evaluated in both brain hemispheres showed a similar PET
signal evolution after ischemia. In the ipsilateral whole brain,
[18F]FLT uptake showed a significant increase at day 7 after
ischemia in comparison to baseline (p < 0.05, Figure 2A).
Subsequently, the PET signal displayed a decline during days 14
and 28 after stroke. In the contralateral whole brain, [18F]FLT
signal showed similar values along the different days evaluated
(Figure 2B). The ischemic cerebral cortex showed a significant
PET signal increase at day 7 after ischemia in comparison to
control rats followed a progressive decrease from days 14 to 28
after MCAO (p < 0.001, Figure 2C). The contralateral cerebral
cortex showed similar values at different days after ischemia
in relation to control values (Figure 2D). Moreover, cerebral
cortex showed higher PET signal values (0.15–0.20%ID/cc) in
relation to striatum (circa 0.10% ID/cc) in control rats, probably
due to spill-over effects from the [18F]FLT PET signal coming
from boundary tissues outside the brain. The injured striatum
showed [18F]FLT PET signal uptake during the first week
after reperfusion followed by a sharp decrease at the third
and fourth week after ischemia (p < 0.001 with respect to
control animals, Figure 2E). Finally, the contralateral striatum
FIGURE 1 | Positron emission tomography (PET) images of [18F]FLT and
Magnetic resonance imaging (MRI) [T2-weighthing (T2W)] before (control) and
at days 1, 7, 14, and 28 after cerebral ischemia in rats. [18F]FLT PET (A, C–E)
and MRI-T2W (B) images of axial and coronal planes at the level of the lesion
are shown. Images correspond to representative animals for each time point.
displayed non-significant PET signal changes at different days
after MCAO (Figure 2F).
Brain Lesion Evolution After Ischemia
MRI-T2W image hyperintensities showed the formation of
vasogenic edema as the consequence of brain infarction evolution
at day 1 after ischemia onset (Figure 3A). Cortical and striatal
MRI alterations coincided with the increase of [18F]FLT PET as
potential marker for gliogenesis and the activation of microglia
and infiltrated macrophages at day 7 (Figure 3B) followed by
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FIGURE 2 | Time course of the progression of [18F]FLT PET signals at before (control) and after cerebral ischemia.%ID/cc (mean ± SD) of [18F]FLT was quantified in
six VOIs. The entire ipsilateral cerebral hemisphere (A), contralateral hemisphere (B), ipsilateral cerebral cortex (C), contralateral cerebral cortex (D), ipsilateral
striatum (E) and contralateral striatum (F) are shown. The upper right panels of each figure show the selected brain ROIs for the quantification defined on a slice of a
MRI (T2W) template. Rats were examined by PET at control (n = 8) and at 7 (n = 8), 14 (n = 5), and 28 (n = 7) days after ischemia. *p < 0.05, **p < 0.01 compared
with control.
a decrease at day 28 (Figure 3C) after ischemia. The infarcted
area (cerebral cortex and striatum) was occupied by cells with
the morphology of amoeboid reactive microglia/macrophages
showing intense CD11b immunoreactivity flanked by reactive
astrocytes (GFAP+ cells) at day 7 after MCAO (Figure 3D).
Some of these glial cells were positive for the proliferation marker
Ki67, supporting the detection of glial proliferation by PET using
[18F]FLT. During following weeks, brain infarction evolved into
a cystic cavity surrounded by the formation of the astrocytic
scar (Figure 3E).
Ex vivo Evaluation of Glial Proliferation
After MCAO
The ischemic cerebral cortex showed a significant increase of
proliferative microglia/infiltrated macrophages (in red-CD11b
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FIGURE 3 | MRI-T2W and [18F]FLT PET signal shows the vasogenic edema
and the evolution of cerebral proliferation at days 1 (A), 7 (B), and 28 (C) after
MCAO. Images correspond to the same animal. Immunofluorescent labeling
of GFAP (green), Ki67 (blue) and CD11b (red) of an axial section at days 7 (D)
and 28 (E) shows gliogenesis after cerebral ischemia. Scale bar, 20 µm.
and blue-Ki67; Figure 4) at day 7 in comparison to control
brains followed by a slight decrease at day 14 and a sharp
decline at day 28 after ischemia (p < 0.001, Figure 6A), In
contrast, the number of proliferative astrocytes (in green-GFAP
and blue-Ki67; Figure 4) showed pseudo-control values at day
7 followed by a mild non-significant increase at 14 and 28 days
after cerebral ischemia (Figure 6A). Despite the number of
CD11+/Ki67+ was much higher than GFAP+/ki67+cells at days
7 and 14, the values of both proliferative glial cells were similar
at day 28 after MCAO (Figure 6A). In the non-ischemic cerebral
cortex (contralateral), both proliferative microglia and astrocytes
showed low values at different days after ischemia (Figure 6B).
Similarly, the ischemic striatum showed a significant increase
of CD11+/Ki67+ (in red and blue; Figure 5) followed by a
progressive decrease from days 14 to 28 after cerebral ischemia
(p < 0.05; p < 0.01, Figure 6C). Likewise, the number of
proliferative astrocytes showed a progressive mild increase from
days 7 to 14 followed by the highest value reached at day 28 after
MCAO (p < 0.05; p < 0.001, Figure 6C). In contrast, very low
proliferative glial was observed in the contralateral striatum at the
different time points after ischemia (Figure 6D). Cerebral cortex
showed non-significant higher values of proliferative microglia
and infiltrated macrophages at days 7 and 14 in relation to the
striatum, while this situation was reverted at day 28 (Figure 6E).
In the other hand, striatum showed non-significant increase
of proliferative astrocytes in comparison to cerebral cortex at
different days after stroke (Figure 6F).
DISCUSSION
The neuroinflammatory reaction, firstly led by the activation
of microglia and the infiltration of macrophages and later by
the over-reactivity of astrocytes, has been extensively monitored
with PET after ischemic stroke (Rojas et al., 2007; Martin et al.,
2010). However, new functions and properties of proliferative
glia that might account for neuronal restoration (Rusznak et al.,
2016) after brain ischemia have been barely studied so far. To
fill this gap, we explored a novel non-invasive in vivo imaging
method able to detect proliferation of microglia/macrophages
and astrocytes after stroke in rats by using [18F]FLT PET.
Previously, Rueger and colleagues described the use of
[18F]FLT PET as imaging method of endogenous neural stem
cells (NSCs) after cerebral ischemia in rats (Rueger et al.,
2010). This study showed for the first time the uptake of
[18F]FLT in both NSC niches, the subventricular area and the
hippocampus that correlated with a high bromodeoxyuridine
(BrdU) accumulation in those brain regions. Additionally, these
authors also described a cellular proliferation enhancement
within the infarcted region with both [18F]FLT and BrdU staining
at 1 week after preclinical stroke. However, these results were
not directly related to the proliferation of glial cells rather than
a merely increase of cellular proliferation after stroke (Rueger
et al., 2010). Therefore, these latter findings are fully consistent
with PET imaging results observed in our work (Figure 1). In
the present study, the PET [18F]FLT signal uptake showed a
significant increase at day 7 after ischemia that was followed by
a progressive decline to pseudo-control values at day 28 after
reperfusion (Figure 2). In fact, these results stand in agreement
with the in vivo PET imaging distribution of TSPO, a well-
known marker of neuroinflammation, after cerebral ischemia
(Domercq et al., 2016). Hence, taking into account that the
TSPO overexpression is principally due to the activation of
microglia/infiltrated macrophages and astrocytes (Martin et al.,
2010), our results could suggest that [18F]FLT signal in the region
of infarction can be linked to the inflammatory reaction. To
verify this hypothesis, we performed the immunohistochemical
characterization of proliferative microglia/macrophages and
astrocytes at days 7, 14, and 28 after ischemia (Figures 3–5).
In the present study, we evaluated the proliferative glial cells
using the marker Ki67, a nuclear protein expressed in all phases
of the cell cycle except the resting state. A previous study showed
higher numbers of Ki67 positive cells in comparison to BrdU
expression pattern in the rat brain. In fact, these findings might
be due to BrdU is incorporated to DNA during the S-phase of
the mitotic process, whereas Ki67 might be incorporated during
all phases (Kee et al., 2002). Additionally, [18F]FLT has shown
to be a thymidine analog that is trapped inside proliferative cells
during the S-phase in a similar manner than BrdU. However,
previous works showed lower [18F]FLT values in comparison
to BrdU positive cells based on differences in their incubation
times (i.e., from 1.5 to 6 h, respectively) (Rueger et al., 2010,
2012). Therefore, all these previous findings may explain the
higher events observed in our study by immunohistochemistry
with Ki67 positive cells in comparison to the PET signal with
[18F]FLT (Figures 4–6). Despite this, these results showed a
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FIGURE 4 | Immunofluorescent labeling of DAPI (white), GFAP (green), CD11b (red) and Ki67 (blue) in the ischemic cortex, shown as four channels. The data show
temporal evolution of cortical proliferative (Ki+) microglia/macrophages (CD11b+) and astrocytes (GFAP+) at day 0 (control; first row), day 7 (second row), day 14
(third row), and day 28 (fourth row) after ischemia. Scale bars, 10 µm.
FIGURE 5 | Immunofluorescent labeling of DAPI (white), GFAP (green), CD11b (red) and Ki67 (blue) in the ischemic striatum, shown as four channels. The data show
temporal evolution of striatal proliferative (Ki+) microglia/macrophages (CD11b+) and astrocytes (GFAP+) at day 0 (control; first row), day 7 (second row), day 14
(third row), and day 28 (fourth row) after ischemia. Scale bars, 10 µm.
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FIGURE 6 | Temporal profiles of CD11b+/Ki67+ and GFAP+/Ki67+ cells in four brain regions after ischemia onset. Ipsilateral cerebral cortex (A), contralateral
cerebral cortex (B), ipsilateral striatum (C) and contralateral striatum (D) are shown. CD11b+/Ki67+ (E) and GFAP+/Ki67+ (F) cells show evolution of proliferative
glial cells in cerebral cortex and striatum. Cell counts/mm2 were counted before (control) and days 7, 14, and 28 (n = 12, 4 rats/time point) after ischemia. *p < 0.05,
**p < 0.01, ***p < 0.001 compared with control.
significant increase of proliferative microglia/macrophages at
day 7 followed by a decrease from days 14 to 28 supporting
the findings observed with [18F]FLT. In contrast, the number
of proliferative astrocytes showed low levels during the first
two weeks that was significantly increased at day 28 after
ischemia. The increase of proliferative astroglial cells at day
28 was not paralleled by increased [18F]FLT uptake, which
displayed pseudo-control values in both cerebral cortex and
striatum one month after ischemia. In fact, these differences
could be explained by the higher resolution showed by confocal
microscopy in relation to PET imaging which allows for a more
accurate detection of proliferative cells in the region of infarction
(Tichauer et al., 2015).
Overall, our study showed that [18F]FLT PET was able
to detect mainly proliferative CD11b positive cells (microglia
and infiltrated macrophages) that accounted for the highest
proliferative cellular population in the ischemic area at
day 7 after stroke.
Summary and Conclusion
In summary, we report here for the first time a novel imaging tool
to evaluate glial proliferation using PET imaging. We describe
a novel imaging tool to evaluate glial proliferation with PET
since [18F]FLT is a radiotracer able to detect cellular proliferation
in vivo. Following cerebral ischemia, a massive amount of glial
cells become activated and others proliferate too. Since neuronal
population dies in the region of the infarction after stroke, we
might be able to monitor proliferative glial cells involved in
the immune response. Therefore, these results provide valuable
information regarding the in vivo detection of proliferative glia
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after stroke that might contribute to the discovery of novel
diagnostic tools for stroke care.
Limitation Section
The main limitations of the present study are as follows: (i) the
resolution of current PET cameras might certainly limit the use
of this imaging technique for the evaluation of low proliferative
glial density, (ii) the no correction to compensate for the effect
of the surface coil in MRI studies, (iii) the regions of interest of
MRI images were drawn by less than two researchers, and (iv) the
count of cells was carried out manually.
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